Neurological and pancreatic complications are common in patients with congenital hyperinsulinism, according to a systematic ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage ultra-rare disease company focused on treating refractory hypoglycemia caused by a congenital or any acquired form of hyperinsulinism (HI), ...

A number of congenital disorders characterized by low blood sugar levels (hypoglycemia) as a result of excessive secretion of the hormone insulin are collectively known as congenital hyperinsulinism.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...

Prolonged sitting emerges as a significant independent risk factor for colorectal cancer. New data shows increased risk with ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A mom of three became concerned after her newborn son stopped growing ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Dr B Glaser, Division of Endocrinology and Metabolism, Hadassah University Hospital, PO Box 12000, Jerusalem, Israel email: beng{at}cc.huji.ac.il Congenital hyperinsulinism (HI) is a clinically and ...

Researchers found that insulin-producing cells depend on a team of helper proteins to keep insulin production on track. When one key partner was missing, damaged proteins built up and the cells made ...

WSW, NY, July 22nd, 2026, FinanceWireTen billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay ...